The Uterotrophic Bioassay is intended to be included in a battery of in vitro and in vivo tests to identify chemicals with potential to interact with the endocrine system, ultimately leading to risk assessments for human health or the environment.
Cela garantira un poids utérin de référence peu élevé et le plus large éventail possible de réponses aux œstrogènes administrés.